Radiation-induced sarcoma after high-dose thoracic radiation therapy in non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 25, Issue 12, 2007, Pages 1621-1623

  Stinchcombe, Thomas E ^a   Walters, Ruth ^b   Khandani, Amir H ^a   Socinksi, Mark A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ANOREXIA; ARTICLE; BRONCHOSCOPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DYSPHAGIA; ESOPHAGUS CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHADENOPATHY; MALE; MEDIASTINOSCOPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; SARCOMA; SHOULDER PAIN; THORAX PAIN; THORAX RADIOGRAPHY; WEIGHT REDUCTION; BRACHYTHERAPY; CANCER STAGING; FOLLOW UP; LUNG TUMOR; MEDIASTINUM TUMOR; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; RADIATION INJURY; RISK ASSESSMENT;

BIOPSY, NEEDLE; BRACHYTHERAPY; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SARCOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34248194910     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.3267     Document Type: Article

References (11)

1. Socinski MA, Rosenman J, Halle J, et al: Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B non-small cell lung cancer: A modified phase I trial. Cancer 89:534-542, 2000
2. Zablotska LB, Neugut AI: Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 97:1404-1411, 2003
3. Tinger A, Wasserman TH, Klein EE, et al: The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 37:865-870, 1997
4. Brenner DJ, Curtis RE, Hall EJ, et al: Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88:398-406, 2000
5. Yap J, Chuba PJ, Thomas R, et al: Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys 52:1231-1237, 2002
6. Socinski M, Halle JS, Morris DE, et al: Long-term results of aggressive combined modality therapy employing induction and concurrent carboplatin/paclitaxel with dose-escalated thoracic conformal radiation therapy. Lung Cancer 41:S239, 2003
7. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
8. Blackstock AW, Socinski MA, Bogart J, et al: Induction (Ind) plus concurrent (Con) chemotherapy with high-dose (74 Gy) 3-dimensional (3-D) thoracic radiotherapy (TRT) in stage III non-small cell lung cancer (NSCLC): Preliminary report of Cancer and Leukemia Group B (CALGB) 30105. J Clin Oncol 24: 374s, 2006 (abstr 7042)
9. Bradley J, Graham MV, Winter K, et al: Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61:318-328, 2005
10. Schild SE, McGinnis WL, Graham D, et al: Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65:1106-1111, 2006
11. Lee CB, Stinchcombe TE, Rosenman JG, et al: Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: Evolving role of dose-escalated conformal (3-dimensional) radiation therapy. Clinical Lung Cancer 8:195-202, 2006